Marketing-authorisation holder · United States
Chartwell Rx
64 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
64 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 64
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTICLATE150mg base | 75mg base · Tablet | Doxycycline | United States | Marketed | 2014 |
| ACTICLATE CAP75mg base · Capsule | Doxycycline | United States | Not marketed | 2016 |
| ALBUTEROL SULFATE2mg base/5ml · Syrup | Salbutamol | United States | Marketed | 1992 |
| AMILORIDE HYDROCHLORIDE5MG · Tablet | Amiloride | United States | Marketed | 1986 |
| AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE5mg anhydrous; 50mg · Tablet | Amiloride, Hydrochlorothiazide | United States | Marketed | 1987 |
| ATOVAQUONE750mg/5ml · Suspension | Atovaquone | United States | Marketed | 2014 |
| AZITHROMYCIN100mg base/5ml | 200mg base/5ml · For suspension | Azithromycin | United States | Marketed | 2006 |
| CAM-AP-ES25mg; 15mg; 0.1mg · Tablet | Hydralazine, Hydrochlorothiazide, Reserpine | United States | Not marketed | 1979 |
| CAPTOPRIL100mg | 12.5mg | 25mg | 50mg · Tablet | Captopril | United States | Marketed | 1995 |
| CARBAMAZEPINE100mg/5ml · Suspension | Carbamazepine | United States | Marketed | 2000 |
| CHLORZOXAZONE250mg | 375mg | 500mg | 750mg · Tablet | Chlorzoxazone | United States | Marketed | 1981 |
| CITALOPRAM HYDROBROMIDE10mg base | 20mg base | 40mg base · Tablet | Citalopram | United States | Marketed | 2004 |
| CLOVIQUE250mg · Capsule | Trientine | United States | Not marketed | 2019 |
| CORPHED60mg; 2.5mg · Tablet | Pseudoephedrine, Triprolidine | United States | Not marketed | 1985 |
| CYPROHEPTADINE HYDROCHLORIDE4MG | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Cyproheptadine | United States | Marketed | 1979 |
| DUVOID10mg | 25mg | 50mg · Tablet | Bethanechol | United States | Marketed | 1978 |
| EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE300mg | 600mg | 600mg; 200mg; 300mg · Tablet | Efavirenz, Emtricitabine, Tenofovir disoproxil | United States | Marketed | 2023 |
| ESZOPICLONE1mg | 2mg | 3mg · Tablet | Eszopiclone | United States | Marketed | 2011 |
| ETHOSUXIMIDE250mg/5ml · Syrup | Ethosuximide | United States | Marketed | 1993 |
| FENOFIBRATE (MICRONIZED)130mg | 134mg | 200mg | 43mg | 67mg · Capsule | Fenofibrate | United States | Marketed | 2002 |
| FENOFIBRIC ACID135mg fenofibric acid | 45mg fenofibric acid · Capsule, delayed release | Choline fenofibrate | United States | Marketed | 2013 |
| FLOWTUSS200mg/5ml; 2.5mg/5ml · Solution | Guaifenesin, Hydrocodone | United States | Not marketed | 2015 |
| FLUOROPLEX1% · Cream | Fluorouracil | United States | Not marketed | 1971 |
| FLURANDRENOLIDE0.05% · Cream | Fludroxycortide | United States | Not marketed | 2016 |
| FULVICIN P/G125mg | 250mg · Tablet | Griseofulvin, Ultramicrosize | United States | Marketed | 1982 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 64 | 63 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.